These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. CXCL9 Predicts Severity at the Onset of Chronic Graft-versus-host Disease. Giesen N; Schwarzbich MA; Dischinger K; Becker N; Hummel M; Benner A; Radujkovic A; Müller-Tidow C; Dreger P; Luft T Transplantation; 2020 Nov; 104(11):2354-2359. PubMed ID: 31929430 [TBL] [Abstract][Full Text] [Related]
11. EASIX for prediction of survival in lower-risk myelodysplastic syndromes. Merz A; Germing U; Kobbe G; Kaivers J; Jauch A; Radujkovic A; Hummel M; Benner A; Merz M; Dreger P; Luft T Blood Cancer J; 2019 Nov; 9(11):85. PubMed ID: 31712595 [TBL] [Abstract][Full Text] [Related]
12. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate. Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856 [TBL] [Abstract][Full Text] [Related]
13. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Bartelink IH; Lalmohamed A; van Reij EM; Dvorak CC; Savic RM; Zwaveling J; Bredius RG; Egberts AC; Bierings M; Kletzel M; Shaw PJ; Nath CE; Hempel G; Ansari M; Krajinovic M; Théorêt Y; Duval M; Keizer RJ; Bittencourt H; Hassan M; Güngör T; Wynn RF; Veys P; Cuvelier GD; Marktel S; Chiesa R; Cowan MJ; Slatter MA; Stricherz MK; Jennissen C; Long-Boyle JR; Boelens JJ Lancet Haematol; 2016 Nov; 3(11):e526-e536. PubMed ID: 27746112 [TBL] [Abstract][Full Text] [Related]
14. Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial. Kennedy GA; Varelias A; Vuckovic S; Le Texier L; Gartlan KH; Zhang P; Thomas G; Anderson L; Boyle G; Cloonan N; Leach J; Sturgeon E; Avery J; Olver SD; Lor M; Misra AK; Hutchins C; Morton AJ; Durrant ST; Subramoniapillai E; Butler JP; Curley CI; MacDonald KPA; Tey SK; Hill GR Lancet Oncol; 2014 Dec; 15(13):1451-1459. PubMed ID: 25456364 [TBL] [Abstract][Full Text] [Related]
15. EASIX (endothelial activation and stress index) predicts mortality in patients with coronary artery disease. Finke D; Hund H; Frey N; Luft T; Lehmann LH Clin Res Cardiol; 2024 Sep; ():. PubMed ID: 39256221 [TBL] [Abstract][Full Text] [Related]
16. Pretransplantation EASIX predicts intensive care unit admission in allogeneic hematopoietic cell transplantation. Peña M; Salas MQ; Mussetti A; Moreno-Gonzalez G; Bosch A; Patiño B; Jiménez L; Kara M; Parody R; Sureda A Blood Adv; 2021 Sep; 5(17):3418-3426. PubMed ID: 34495311 [TBL] [Abstract][Full Text] [Related]
17. Surrogates of Endothelial Injury Predict Survival After Post-transplant Cyclophosphamide. Baranwal A; Langer KJ; Kharfan-Dabaja MA; Ayala E; Foran J; Murthy H; Roy V; Iqbal M; Palmer J; Sproat LZ; Chhabra S; Khera N; Durani U; Hefazi M; Mangaonkar A; Shah MV; Litzow MR; Hogan WJ; Alkhateeb HB Transplant Cell Ther; 2024 Aug; ():. PubMed ID: 39154913 [TBL] [Abstract][Full Text] [Related]